Which is wrong regarding EMLA cream
The question is asking which statement is wrong about EMLA. Since the options aren't provided, I have to think about common misconceptions or incorrect facts related to EMLA. Common wrong statements might involve the components, duration, application method, or contraindications.
The core concept would be the pharmacological action of EMLA as a topical anesthetic. The correct answer's explanation would involve how lidocaine and prilocaine work by blocking sodium channels, preventing nerve depolarization. They're in a eutectic mixture, which lowers the melting point, allowing the cream to remain semi-solid at room temperature but melt on the skin.
For the incorrect options, possible wrong answers could be: incorrect components (like adding epinephrine), wrong duration of action (if it's too short or long), improper use in certain age groups (like infants), or wrong application time (like less than 15 minutes). Each wrong option needs a brief explanation of why it's incorrect.
The clinical pearl might be to remember the correct components and the typical application time. Also, noting that EMLA doesn't contain epinephrine, which is a common mistake. High-yield fact: EMLA is lidocaine and prilocaine, 2.5% each, used for topical anesthesia, and requires 30-60 minutes for effect.
Now, structuring the explanation into the required sections. Make sure each part is concise, uses bold terms, and follows the formatting rules. Need to stay within the character limit, so each section must be brief but informative. Check for any medical inaccuracies and ensure the explanations are precise.
**Core Concept**
EMLA (Eutectic Mixture of Local Anesthetics) contains **2.5% lidocaine** and **2.5% prilocaine**. It acts via **sodium channel blockade** in sensory nerves, producing **topical anesthesia** by preventing depolarization of nociceptive fibers.
**Why the Correct Answer is Right**
The incorrect statement about EMLA likely involves **misstating its components** or **mechanism**. For example, if an option claims it contains **epinephrine** (a vasoconstrictor absent in EMLA), this is false. EMLA’s eutectic formulation allows **enhanced skin penetration** due to reduced melting point, enabling effective numbing for procedures like venipuncture or minor skin surgeries.
**Why Each Wrong Option is Incorrect**
**Option A:** *If claiming EMLA contains epinephrine*—EMLA lacks vasoconstrictors; epinephrine is present in other anesthetic mixtures (e.g., lidocaine with epinephrine for infiltration).
**Option B:** *If stating EMLA is a fast-acting agent (5–10 minutes)*—EMLA requires **30–60 minutes